The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals

References

• The Kirby InstituteHIV, Viral Hepatitis and Sexually Transmissible Infections in Australia – Annual Surveillance Report 2015Sydney, AustraliaThe Kirby Institute, University of New South Wales2015
   Google Scholar
• IversenJWandHToppLKaldorJMaherLReduction in hepatitis C virus incidence among injection drug users attending needle and syringe programs in Australia: a linkage studyAm J Public Health201310381436144423763399
   PubMed Web of Science ®Google Scholar
• SabateEAdherence to Long-Term Therapies: Evidence for ActionGenevaWorld Health Organization2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/enAccessed December 19, 2015
   Google Scholar
• Hepatitis C Virus Infection Consensus Statement Working GroupAustralian Recommendations for the Management of Hepatitis C Virus Infection: A Consensus Statement 2016MelbourneGastroenterological Society of Australia2016
   Google Scholar
• KruegerKPBergerBAFelkeyBMedication adherence and persistence: a comprehensive reviewAdv Ther200522431335616418141
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• BrownMTBussellJKMedication adherence: WHO cares?Mayo Clin Proc201186430431421389250
   PubMed Web of Science ®Google Scholar
• PerrilloRPMarcellinPEffect of newer oral antiviral agents on future treatment of chronic hepatitis BAntivir Ther2010151132220167987
   PubMed Web of Science ®Google Scholar
• LehaneEMcCarthyGAn examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertensionJ Clin Nurs200716469870617402951
   PubMed Web of Science ®Google Scholar
• ClatworthyJBowskillRRankTParhamRHorneRAdherence to medication in bipolar disorder: a qualitative study exploring the role of patients’ beliefs about the condition and its treatmentBipolar Disord20079665666417845282
   PubMed Web of Science ®Google Scholar
• KatonWRussoJLinEHDiabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?Psychosom Med200971996597219834047
   PubMed Web of Science ®Google Scholar
• JungEPickardASSalmonJWBartleBLeeTAMedication adherence and persistence in the last year of life in COPD patientsRespir Med2009103452553419136240
   PubMed Web of Science ®Google Scholar
• HeislerMChoiHRosenABHospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysisMed Care2010482879420068489
   PubMed Web of Science ®Google Scholar
• LabaTLLehnbomEBrienJAJanSUnderstanding if, how and why non-adherent decisions are made in an Australian community sample: a key to sustaining medication adherence in chronic disease?Res Social Adm Pharm201511215416225103184
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO)Adherence to Long-Term Therapies – Evidence for ActionGeneva, SwitzerlandWHO2003
   Google Scholar
• The Pharmacy Guild of AustraliaNational Trial to Test Strategies to Improve Medication Compliance in a Community SettingAustraliaDepartment of Health and Ageing, The Australian Government2008
   Google Scholar
• AfdhalNZeuzemSKwoPION-1 InvestigatorsLedipasvir and sofosbuvir for untreated HCV genotype 1 infectionN Engl J Med2014370201889189824725239
   PubMed Web of Science ®Google Scholar
• AfdhalNReddyKRNelsonDRION-2 InvestigatorsLedipasvir and sofosbuvir for previously treated HCV genotype 1 infectionN Engl J Med2014370161483149324725238
   PubMed Web of Science ®Google Scholar
• BourliereMBronowickiJPde ledinghenVLedipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Lancet Infect Dis201515439740425773757
   PubMed Web of Science ®Google Scholar
• TownsendKPetersenTGordonLAEffect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus treatment with ledipasvir and sofosbuvirAIDS201630226126626691547
   PubMed Web of Science ®Google Scholar
• PetersenTTownsendKGordonLAHigh adherence to all-oral directly acting antiviral hepatitis C treatment among an inner-city patient population in a phase 2a studyHepatol Int201610231031926612014
   PubMed Web of Science ®Google Scholar
• KamblePSWalkerDRMarxSAdherence and discontinuation rates of sofosbuvir-based regimens: modelling real world experience in a large managed care organizationHepatology201562S1iiAvA2A1378A26425960
   PubMedGoogle Scholar
• EvonDMEdwardsAStraubBHurtCBThirumurthyHWohlDAdherence to all-oral HCV treatment in patients with substance and alcohol use disordersHepatology201562S1iiAvA2A1378A26425960
   PubMedGoogle Scholar
• MeyerJPMoghimiYMarcusRLimJKLitwinAHAlticeFLEvidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuumInt J Drug Policy2015261092293526077144
   PubMed Web of Science ®Google Scholar
• LontokEHarringtonPHoweAHepatitis C virus drug resistance-associated substitutions: state of the art summaryHepatology20156251623163226095927
   PubMed Web of Science ®Google Scholar
• No authors listedHepatitis C: only a step away from elimination?Lancet20153859973104525797543
   PubMed Web of Science ®Google Scholar
• GiddingHFLawMGAminJACHOS investigator teamPredictors of deferral of treatment for hepatitis C infection in Australian clinicsMed J Aust2011194839840221495939
   PubMed Web of Science ®Google Scholar
• GrebelyJAlaviMMicallefMETHOS Study GroupTreatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyAddiction2016111231131926451534
   PubMed Web of Science ®Google Scholar
• DoreGJHellardMMatthewsGVAustralian Trial in Acute Hepatitis C Study GroupEffective treatment of injecting drug users with recently acquired hepatitis C virus infectionGastroenterology2010138112313519782085
   PubMed Web of Science ®Google Scholar
• GrebelyJKnightEGenowayKAOptimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportEur J Gastroenterol Hepatol201022327027720425880
   PubMed Web of Science ®Google Scholar
• JackKWillottSMannersJVarnamMAThomsonBJClinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis CAliment Pharmacol Ther2009291384518945252
   PubMed Web of Science ®Google Scholar
• WilkinsonMCrawfordVTippetACommunity-based treatment for chronic hepatitis C in drug users: high rates of compliance with treatment despite ongoing drug useAliment Pharmacol Ther2009291293718752631
   PubMed Web of Science ®Google Scholar
• GrebelyJGenowayKKharaMTreatment uptake and outcomes among current and former injection drug users receiving directly observed treatment within a multidisciplinary group model for the treatment of hepatitis C virus infectionInt J Drug Policy200718543744317854734
   PubMed Web of Science ®Google Scholar
• GuadagninoVTrottaMPMontesanoFNocchiero Study GroupEffectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmesAddiction2007102342343117298650
   PubMed Web of Science ®Google Scholar
• BaruaSGreenwaldRGrebelyJDoreGJSwanTTaylorLERestrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United StatesAnn Intern Med2015163321522326120969
   PubMed Web of Science ®Google Scholar
• Australian Commission on Safety and Quality in Health Care (ACSQHC)Patient-centred care: improving quality and safety through partnerships with patients and consumersSydneyACSQHC2011 Available from: www.safetyandquality.gov.auAccessed March 22, 2016
   Google Scholar
• Australasian Hepatology Association (AHA)The AHA consensus-based nursing guidelines for the care of patients with hepatitis B, hepatitis C, advanced liver disease and hepatocellular carcinomaSydneyAHA2012 Available from: http://www.hepatologyassociation.com.au/about-us/consensus-based-nursing-guidelines/Accessed March 22, 2016
   Google Scholar
• Australasian Hepatology Association (AHA)The AHA practice standards for the hepatology nurseAdelaideAHA2015 Available from: http://www.hepatologyassociation.com.au/about-us/practice-standards/Accessed March 22, 2016
   Google Scholar
• Nursing and Midwifery Board of Australia (NMBA)Registered nurse standards for practiceMelbourneNMBA2016 Available from: http://www.nursingmidwiferyboard.gov.auAccessed June 13, 2016
   Google Scholar
• EvonDMGolinCEBonnerJEGrodenskyCVellozaJAdherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriersJ Clin Gastroenterol2015495e41e5024828358
   PubMed Web of Science ®Google Scholar
• JessupRLInterdisciplinary versus multidisciplinary care teams: do we understand the difference?Aust Health Rev200731333033117669052
   PubMed Web of Science ®Google Scholar
• SubletteVASmithSKGeorgeJMcCafferyKDouglasMWThe hepatitis C treatment experience: Patients’ perceptions of the facilitators of and barriers to uptake, adherence and completionPsychol Health2015308987100425622699
   PubMed Web of Science ®Google Scholar
• Brett HauberAMohamedAFBeamCMedjedovicJMauskopfJPatient preferences and assessment of likely adherence to hepatitis C virus treatmentJ Viral Hepat201118961962720579276
   PubMed Web of Science ®Google Scholar
• FusfeldLAggarwalJDougherCAssessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HEPATITIS C) infectionBMC Infect Dis20131323423701894
   PubMed Web of Science ®Google Scholar
• YounossiZHenryLSystematic review: patient-reported outcomes in chronic hepatitis C – the impact of liver disease and new treatment regimensAliment Pharmacol Ther201541649752025616122
   PubMed Web of Science ®Google Scholar
• TreloarCRanceJBackmundMUnderstanding barriers to hepatitis C virus care and stigmatization from a social perspectiveClin Infect Dis201357Suppl 2S51S5523884066
   PubMed Web of Science ®Google Scholar
• BonnerJEEssermanDEvonDMReliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimensJ Viral Hepat201219531632622497810
   PubMed Web of Science ®Google Scholar
• RintamakiLSDavisTCSkripkauskasSBennettCLWolfMSSocial stigma concerns and HIV medication adherenceAIDS Patient Care STDS200620535936816706710
   PubMed Web of Science ®Google Scholar
• WolfMSDavisTCOsbornCYSkripkauskasSBennettCLMakoulGLiteracy, self-efficacy, and HIV medication adherencePatient Educ Couns200765225326017118617
   PubMed Web of Science ®Google Scholar
• Australian Commission on Safety and Quality in Health Care (ACSQHC)National safety and quality health service standards [September 2012]SydneyACSQHC2012 Available from: www.safetyandquality.gov.auAccessed March 23, 2016
   Google Scholar
• Adherence Project Working GroupOptimising Adherence to Antiretroviral MedicationSydneyAdherence Project Working Group, Roche Products2001
   Google Scholar
• Agency for Healthcare Research and Quality (AHRQ)AHRQ Health Literacy Universal Precautions Toolkit2nd ed [content last reviewed November 2016]. Available from: http://www.ahrq.gov/literacyAccessed March 23, 2016
   Google Scholar
• HellardMSacks-DavisRGoldJHepatitis C treatment for injecting drug users: a review of the available evidenceClin Infect Dis200949456157319589081
   PubMed Web of Science ®Google Scholar
• MathesTAntoineSLPieperDFactors influencing adherence in hepatitis-C infected patients: a systematic reviewBMC Infect Dis20141420324731285
   PubMed Web of Science ®Google Scholar
• WeissJJBräuNStivalaASwanTFishbeinDReview article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence researchAliment Pharmacol Ther2009301142719416131
   PubMed Web of Science ®Google Scholar
• HendersonRRVisariaJBridgesGGDorholtMLevinRJFrazeeSGImpact of specialty pharmacy on telaprevir-containing 3-drug hepatitis C regimen persistenceJ Manag Care Spec Pharm201420121227123425443516
   PubMed Web of Science ®Google Scholar
• RodisJLKibbePEvaluation of medication adherence and quality of life in patients with hepatitis C virus receiving combination treatmentGastroenterol Nurs201033536837320890160
   PubMed Web of Science ®Google Scholar
• NambaSMiyakeKIkedaFNursing support increases the efficacy of interferon treatment in patients with chronic hepatitis CActa Med Okayama201468526326825338482
   PubMed Web of Science ®Google Scholar
• SteelDJJacksonTCGutmannMCHave you been taking your pills? The adherence-monitoring sequence in the medical interviewJ Fam Pract19903032942992307943
   PubMed Web of Science ®Google Scholar
• SheaSCImproving Medication Adherence – How to Talk with Patients About Their MedicationsPhiladelphia, PAWolters Kluwer Health Inc2006
   Google Scholar
• SimoniJMAmicoKRPearsonCRMalowRStrategies for promoting adherence to antiretroviral treatment: a review of the literatureCurr Infect Dis Rep200810651552118945394
   PubMedGoogle Scholar
• LieveldFIvan VlerkenLGSiersemaPDvan ErpecumKJPatient adherence to antiviral treatment for chronic hepatitis B and C: a systematic reviewAnn Hepatol201312338039123619254
   PubMed Web of Science ®Google Scholar
• BruceRDEisermanJAcostaAGoteCLimJKAlticeFLDeveloping a modified directly observed treatment intervention for hepatitis C treatment in a methadone maintenance program: implications for program replicationAm J Drug Alcohol Abuse201238320621222242700
   PubMed Web of Science ®Google Scholar
• TaylorLEDelivering care to injection drug users coinfected with HIV and hepatitis C virusClin Infect Dis200540Suppl 5S355S36115768348
   PubMed Web of Science ®Google Scholar
• GrebelyJRaffaJDMeagherCDirectly observed treatment for the treatment of hepatitis C virus infection in current and former injection drug usersJ Gastroenterol Hepatol20072291519152517645460
   PubMed Web of Science ®Google Scholar
• MatzaLSParkJCoyneKSSkinnerEPMalleyKGWoleverRQDerivation and validation of the ASK-12 adherence barrier surveyAnn Pharmacother200943101621163019776298
   PubMed Web of Science ®Google Scholar
• ByerlyMJNakoneznyPARushAJThe Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorderSchizophr Res20081001–3606918255269
   PubMed Web of Science ®Google Scholar
• MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
   PubMed Web of Science ®Google Scholar